Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India

International Health

Volumn 3, Issue 1, 2011, Pages 22-26

  Nujum, Z T ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

Compliance; Coverage; Lymphatic filariasis; MDA; Two stage Cluster sampling

Indexed keywords

DIETHYLCARBAMAZINE;

ADOLESCENT; ARTICLE; CHILD; DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; DRUG SAFETY; FEAR; FEMALE; HEALTH CARE NEED; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH PROGRAM; HOUSEHOLD; HUMAN; INDIA; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MALE; MASS DRUG ADMINISTRATION; MEDICAL PRACTICE; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 79952629919     PISSN: 18763413     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.inhe.2010.12.001     Document Type: Article

References (27)

1. Michael E., Bundy D.A.P., Grenfell B.T. Reassessing the global prevalence and distribution of Lymphatic filariasis. Parasitology 1996, 112:409-428.
2. Sabesan S., Palaniyandi M., Das P.K., Michael E. Mapping of L.F in India. Ann Trop Med Parasitol 2000, 95:591-606.
3. Ramaiah K.D., Das P.K., Michael E., Guyatt H. The economic burden of LF in India. Parasitol Today 2000, 16:251-253.
4. WHO. Lymphatic filariasis: the disease and its control. Fifth report of the WHO Expert Committee on Filariasis. Geneva: World Health Organization. Technical Report Series 821; 1992.
5. Directorate NMEP. NFCP Operational manual. Delhi: NICD;1995.
6. Rahman S.J., Sharma S.K., Rajgopal R. Manual of entomological surveillance of vector borne diseases 1989, Government of India, Ministry of Health and Family Welfare, Division of Medical Entomology, Delhi.
7. Centers for Disease Control and Prevention Recommendations of the international task force for disease eradication. MMWR 1993, 42:1-32.
8. Fiftieth World Health Assembly. Elimination of lymphatic filariasis as a public health problem. Resolution of the Excecutive Board of the WHO. 13 May 1997. Geneva: World Health Organization; 1997. WHA50.29;.
9. Otteson E.A., Duke B.O., Karam M., Behbebani K. Strategies and tools for the control elimination of Lymphatic filariasis. Bull World Health Organ 1997, 75:491-503.
10. Cao W.C., Van der Ploeg, Plais A.P., Plaisier A.P., Van der Sluijs, Habbema J.D. Ivermectin for the chemotherapy of bancroftian filariasis: a metaanalysis of the effect of single treatment. Trop Med Int Heath 1997, 2:393-403.
11. Ismail M.M., Jayakody R.L., Weil G.J., Nirmalan N., Jayasinghe K.S.A., Abeyewickrema W. Efficacy of single dose combinations of Ivermectin, Albendazole and DEC for the treatment of Bancroftian Filariasis. Trans R Soc Trop Med Hyg 1997, 92:94-97.
12. Thomas B.Nutmann Lymphatic filariasis, tropical medicine science and practice 2000, Imperial College Press, London.
13. WHO. Preparing and implementing a national plan to eliminate lymphatic filariasis. Geneva: World Health Organization; 2002. WHO/CDS/CPE/CEE/2000.15.
14. Regu K., Showkath A.N.M.K., Rajendran R., Koya S.M., Ganesh B., Dhariwal A.C. Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala state. J Commun Dis 2006 Dec, 38:333-338.
15. Rothenberg R.B., Lobanov A., Singh K.B., Stroh G. Observations on the application of EPI cluster survey methods for estimating disease incidence. Bull World Health Organ. 1985, 63:93-99.
16. Evaluate vaccination coverage. National Immunization Programme. New Delhi: Government of India, Ministry of Health and Family Welfare;1989.
17. Babu B.V., Kar S.K. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa. Trop Med Int Health 2004, 9:702-709.
18. Nandha B., Sadanandane C., Jambulingam P., Das P. Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience. Filaria J 2007, 24:6-7.
19. Gyapong J.O., Twum-Danso N.A. Global elimination of lymphatic filariasis: fact or fantasy?. Trop Med Int Health 2006, 11:125-128.
20. Burkot T.R., Taleo G., Toeaso V., Ichimori K. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities. Ann Trop Med Parasitol 2002, 96(Suppl 2):S61-S69.
21. Ramzy R.A., Goldman A.S., Kamal H.A. Defining the cost of the Egyptian lymphatic filariasis elimination programme. Filaria J 2005, 2:4-7.
22. Fraser M., Taleo G., Taleo F., James Y., Morris A., Mark B., et al. Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach. Am J Trop Med Hyg 2005, 73:753-758.
23. Mathieu E., Direny A.N., de Rochars M.B., Streit T.G., Addiss D.G., Lammie P.J. Participation in three consecutive mass drug administrations in Leogane Haiti. Trop Med Int Health 2006, 11:862-868.
24. Weerasooriya M.V., Yahathugoda C.T., Wickramasinghe D., Gunawardena K.N., Dharmadasa R.A., Vidanapathirana K.K., et al. Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka. Filaria J 2007, 6:11.
25. Showkath A.N.M.K., Rajendran R., Regu K., Mohanan M.K., Dhariwal A.C., Lai S. Study on factors affecting the MDA Programme in Kerala state. J Commun Dis 2007, 39:51-56.
26. Krishnamoorthy K., Das L.K., Sabesan S., Subramanian S., Nilamani N., Pani S.P. Lymphatic filariasis elimination programme in India: an update. Indian J Lymphol 2006, 3:31-45.
27. Burkot T., Durrheim D., Melrose W., Speare R., Ichimori K. The argument for integrating vector control with mass drug administration campaigns to ensure elimination of lymphatic filariasis. Filaria J. 2006, 5:10.